Thursday, April 20, 2017

April - HCV Next: HCC After DAAs Requires More Study, but no Cause for Withheld Treatment
"HCV Next" offers information on a range of topics, which include diagnosis, new combination therapies, side effects, drug/drug interaction, guidelines, practice management issues, to name a few.

The following articles appeared in the April print edition of HCV NEXT, provided online at Healio.

Recommended Reading
Meeting Coverage Healio
International Liver Congress

International Liver Congress™ 2017
Updates On This Blog

Updated April 20, 2017
Liver Cancer After Treatment For Hepatitis C
​Research demonstrates that while SVR markedly reduced liver-related complications and liver cancer, some long-term risk for liver cancer remained in those who were cured of Hepatitis C. But after direct-acting antiviral therapy does the risk of developing liver cancer increase?

No comments:

Post a Comment